Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000230284 is a processed pseudogene with sequence similarity to the human ribosomal protein L7 (RPL7) gene[2][3]. Unlike the protein-coding RPL7 gene (which codes for a component of the 60S ribosomal subunit), this pseudogene does not code for a functional protein and there is no evidence that it has a physiological, pathological, or therapeutic relevance[2][3]. Such pseudogenes are common in the human genome, particularly for ribosomal proteins, and are generally regarded as non-functional genomic elements[2]. Their main utility is typically restricted to evolutionary or genomic studies, not as drug targets. Note: The functional RPL7 gene and protein (not this pseudogene) are involved in ribosome structure and function, but the pseudogene itself has no canonical activity or established role in disease or therapy[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of ribosomal protein L7.